Unleash Immuno Oncolytics Overview

  • Founded
  • 2016

  • Status
  • Out of Business

  • Employees
  • 4

  • Latest Deal Type
  • Out of Business

Unleash Immuno Oncolytics General Information


Developer of oncolytic virus immunotherapy products designed to treat cancer. The company's products include UIO-512, which is an oncolytic virus designed for targeting both malignant cells and tumor-associated stromal cells, enabling patients to start cancer treatment more quickly, resulting in a better medical outcome.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4320 Forest Park Avenue
  • Suite 304
  • Saint Louis, MO 63108
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unleash Immuno Oncolytics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2022 00.00 Completed Out of Business
3. Early Stage VC 19-Feb-2018 00.00 00.00 Completed Generating Revenue
2. Seed Round 12-May-2016 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Unleash Immuno Oncolytics’s complete valuation and funding history, request access »

Unleash Immuno Oncolytics Patents

Unleash Immuno Oncolytics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3927833-A1 Oncolytic adenoviral vector and methods of use Pending 21-Feb-2019 000000000
US-20200270639-A1 Oncolytic adenoviral vector and methods of use Pending 21-Feb-2019 000000000

Unleash Immuno Oncolytics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial